SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001214659-24-002001
Filing Date
2024-02-06
Accepted
2024-02-06 16:04:53
Documents
1
Group Members
OCTAGON INVESTMENTS MASTER FUND LPTING JIA

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 j21244sc13ga2.htm SC 13G/A 61878
  Complete submission text file 0001214659-24-002001.txt   63507
Mailing Address 654 MADISON AVENUE 21ST FLOOR NEW YORK NY 10065
Business Address 654 MADISON AVENUE 21ST FLOOR NEW YORK NY 10065 212-369-2829
Octagon Capital Advisors LP (Filed by) CIK: 0001839435 (see all company filings)

IRS No.: 843576791 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Subject) CIK: 0001840233 (see all company filings)

IRS No.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92962 | Film No.: 24600196
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)